Thomson Medical warns of H1 loss on poorer Malaysia performance
It has been hit by the termination and discounts of certain insurance contracts
THOMSON Medical expects to report a loss after tax for the six months ended Dec 31, 2024, following a preliminary review of the unaudited financial results.
This is mainly due to poorer performance of its Malaysia market, partly resulting from the termination and discounts of certain insurance contracts, it said in a bourse filing on Friday (Jan 24).
The hospital operator also had increased interest expenses from the acquisition of Far East Medical Vietnam, as well as cessation of projects in Singapore.
Further details of the financial performance for its first half will be disclosed on or before Feb 14, it said.
Shares of Thomson Medical closed flat at S$0.049 on Friday, before the announcement.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
If Europe goes to war, the fallout will be felt in East Asia
Keppel posts 20% rise in Q3 net profit; New Keppel earnings up 15%
CICT Q3 NPI rises 13.8% to S$334.9 million on contributions from Paragon and other acquisitions
Stocks to watch: Keppel, CICT, MLT, Golden-Agri, Wilmar, CDLHT, FEHT, UltraGreen.ai